{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T05:28:42Z","timestamp":1771478922770,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T00:00:00Z","timestamp":1526947200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Matthew\u2019s Hearts of Hope Inc."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Cardiol"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s00246-018-1910-z","type":"journal-article","created":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T11:15:53Z","timestamp":1526987753000},"page":"1404-1412","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Two-Dimensional Speckle Tracking Echocardiography-Derived Strain Measurements in Survivors of Childhood Cancer on Angiotensin Converting Enzyme Inhibition or Receptor Blockade"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2220-4712","authenticated-orcid":false,"given":"Jamie K.","family":"Harrington","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc E.","family":"Richmond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arielle W.","family":"Fein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serge","family":"Kobsa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prakash","family":"Satwani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amee","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,5,22]]},"reference":[{"key":"1910_CR1","volume-title":"SEER cancer statistics, review, 1975\u20132010","author":"N Howlander","year":"2014","unstructured":"Howlander N, Noone A, Krapcho M (2014) SEER cancer statistics, review, 1975\u20132010. National Cancer Institute, Bethesda"},{"key":"1910_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ppedcard.2014.09.003","volume":"36","author":"GT Armstrong","year":"2014","unstructured":"Armstrong GT, Ross JD (2014) Late cardiotoxicity in aging adult survivors of childhood cancer. Prog Pediatr Cardiol 36:19\u201326. \n                    https:\/\/doi.org\/10.1016\/j.ppedcard.2014.09.003","journal-title":"Prog Pediatr Cardiol"},{"key":"1910_CR3","doi-asserted-by":"publisher","first-page":"1218","DOI":"10.1200\/JCO.2013.51.1055","volume":"32","author":"GT Armstrong","year":"2014","unstructured":"Armstrong GT, Kawashima T, Leisenring W et al (2014) Aging and risk of severe, disabling, life-threatening, and fatal events in the childhood cancer survivor study. J Clin Oncol 32:1218\u20131227. \n                    https:\/\/doi.org\/10.1200\/JCO.2013.51.1055","journal-title":"J Clin Oncol"},{"key":"1910_CR4","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1097\/CRD.0000000000000030","volume":"22","author":"JC Hochberg","year":"2014","unstructured":"Hochberg JC, Cairo MS, Friedman DM (2014) Cardio-oncology issues among pediatric cancer and stem cell transplant survivors. Cardiol Rev 22:268\u2013274. \n                    https:\/\/doi.org\/10.1097\/CRD.0000000000000030","journal-title":"Cardiol Rev"},{"key":"1910_CR5","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1056\/NEJMsa060185","volume":"355","author":"KC Oeffinger","year":"2006","unstructured":"Oeffinger KC, Mertens AC, Sklar CA et al (2006) Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 355:1572\u20131582. \n                    https:\/\/doi.org\/10.1056\/NEJMsa060185","journal-title":"N Engl J Med"},{"key":"1910_CR6","doi-asserted-by":"publisher","first-page":"4979","DOI":"10.1200\/JCO.2004.11.032","volume":"22","author":"W Landier","year":"2004","unstructured":"Landier W, Bhatia S, Eshelman DA et al (2004) Development of risk-based guidelines for pediatric cancer survivors: the children\u2019s oncology group long-term follow-up guidelines from the children\u2019s oncology group late effects committee and nursing discipline. J Clin Oncol 22:4979\u20134990. \n                    https:\/\/doi.org\/10.1200\/JCO.2004.11.032","journal-title":"J Clin Oncol"},{"key":"1910_CR7","doi-asserted-by":"publisher","first-page":"672","DOI":"10.7326\/M13-2498","volume":"160","author":"FL Wong","year":"2014","unstructured":"Wong FL, Bhatia S, Landier W et al (2014) Cost-effectiveness of the children\u2019s oncology group long-term follow-up screening guidelines for childhood cancer survivors at risk for treatment-related heart failure. Ann Intern Med 160:672. \n                    https:\/\/doi.org\/10.7326\/M13-2498","journal-title":"Ann Intern Med"},{"key":"1910_CR8","doi-asserted-by":"publisher","first-page":"vii155-vii166","DOI":"10.1093\/annonc\/mds293","volume":"23","author":"G Curigliano","year":"2012","unstructured":"Curigliano G, Cardinale D, Suter T et al (2012) Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO clinical practice guidelines. Ann Oncol 23:vii155-vii166. \n                    https:\/\/doi.org\/10.1093\/annonc\/mds293","journal-title":"Ann Oncol"},{"key":"1910_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/eurjhf\/hfq213","volume":"13","author":"T Eschenhagen","year":"2011","unstructured":"Eschenhagen T, Force T, Ewer MS et al (2011) Cardiovascular side effects of cancer therapies: a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 13:1\u201310. \n                    https:\/\/doi.org\/10.1093\/eurjhf\/hfq213","journal-title":"Eur J Heart Fail"},{"key":"1910_CR10","unstructured":"Children\u2019s Oncology Group. \n                    http:\/\/www.survivorshipguidelines.org\/\n                    \n                  . Accessed 19 Apr 2017"},{"key":"1910_CR11","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1161\/CIRCULATIONAHA.115.016704","volume":"131","author":"JD Groarke","year":"2015","unstructured":"Groarke JD, Nohria A, Middleman E et al (2015) Anthracycline cardiotoxicity: a new paradigm for an old classic. Circulation 131:1946\u20131949. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.115.016704","journal-title":"Circulation"},{"key":"1910_CR12","doi-asserted-by":"publisher","first-page":"647","DOI":"10.2217\/fca.12.44","volume":"8","author":"D Harake","year":"2012","unstructured":"Harake D, Franco VI, Henkel JM et al (2012) Cardiotoxicity in childhood cancer survivors: strategies for prevention and management. Future Cardiol 8:647\u2013670. \n                    https:\/\/doi.org\/10.2217\/fca.12.44","journal-title":"Future Cardiol"},{"key":"1910_CR13","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/nrclinonc.2013.195","volume":"10","author":"SE Lipshultz","year":"2013","unstructured":"Lipshultz SE, Cochran TR, Franco VI, Miller TL (2013) Treatment-related cardiotoxicity in survivors of childhood cancer. Nat Rev Clin Oncol 10:697\u2013710. \n                    https:\/\/doi.org\/10.1038\/nrclinonc.2013.195","journal-title":"Nat Rev Clin Oncol"},{"key":"1910_CR14","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/HCO.0000000000000034","volume":"29","author":"SE Lipshultz","year":"2014","unstructured":"Lipshultz SE, Karnik R, Sambatakos P et al (2014) Anthracycline-related cardiotoxicity in childhood cancer survivors. Curr Opin Cardiol 29:103\u2013112. \n                    https:\/\/doi.org\/10.1097\/HCO.0000000000000034","journal-title":"Curr Opin Cardiol"},{"key":"1910_CR15","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1200\/JCO.2010.30.3404","volume":"30","author":"SE Lipshultz","year":"2012","unstructured":"Lipshultz SE, Miller TL, Scully RE et al (2012) Changes in cardiac biomarkers during doxorubicin treatment of pediatric patients with high-risk acute lymphoblastic leukemia: associations with long-term echocardiographic outcomes. J Clin Oncol 30:1042\u20131049. \n                    https:\/\/doi.org\/10.1200\/JCO.2010.30.3404","journal-title":"J Clin Oncol"},{"key":"1910_CR16","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2174\/157340309788166642","volume":"5","author":"M Dandel","year":"2009","unstructured":"Dandel M, Lehmkuhl H, Knosalla C et al (2009) Strain and strain rate imaging by echocardiography: basic concepts and clinical applicability. Curr Cardiol Rev 5:133\u2013148. \n                    https:\/\/doi.org\/10.2174\/157340309788166642","journal-title":"Curr Cardiol Rev"},{"key":"1910_CR17","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.ihj.2012.12.004","volume":"65","author":"M Bansal","year":"2013","unstructured":"Bansal M, Kasliwal RR (2013) How do I do it? Speckle-tracking echocardiography. Indian Heart J 65:117\u2013123. \n                    https:\/\/doi.org\/10.1016\/j.ihj.2012.12.004","journal-title":"Indian Heart J"},{"key":"1910_CR18","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1016\/j.jacc.2014.01.073","volume":"63","author":"P Thavendiranathan","year":"2014","unstructured":"Thavendiranathan P, Poulin F, Lim K-D et al (2014) Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review. J Am Coll Cardiol 63:2751\u20132768. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2014.01.073","journal-title":"J Am Coll Cardiol"},{"key":"1910_CR19","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.3892\/etm.2011.305","volume":"2","author":"M Dess\u00ec","year":"2011","unstructured":"Dess\u00ec M, Piras A, Madeddu C et al (2011) Long-term protective effects of the angiotensin receptor blocker telmisartan on epirubicin-induced inflammation, oxidative stress and myocardial dysfunction. Exp Ther Med 2:1003\u20131009. \n                    https:\/\/doi.org\/10.3892\/etm.2011.305","journal-title":"Exp Ther Med"},{"key":"1910_CR20","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/2193-1801-2-198","volume":"2","author":"M Dess\u00ec","year":"2013","unstructured":"Dess\u00ec M, Madeddu C, Piras A et al (2013) Long-term, up to 18 months, protective effects of the angiotensin II receptor blocker telmisartan on Epirubin-induced inflammation and oxidative stress assessed by serial strain rate. Springerplus 2:198. \n                    https:\/\/doi.org\/10.1186\/2193-1801-2-198","journal-title":"Springerplus"},{"key":"1910_CR21","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1161\/CIRCULATIONAHA.114.013777","volume":"131","author":"D Cardinale","year":"2015","unstructured":"Cardinale D, Colombo A, Bacchiani G et al (2015) Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy. Circulation 131:1981\u20131988. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.114.013777","journal-title":"Circulation"},{"key":"1910_CR22","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1161\/CIRCULATIONAHA.106.635144","volume":"114","author":"D Cardinale","year":"2006","unstructured":"Cardinale D, Colombo A, Sandri MT et al (2006) Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition. Circulation 114:2474\u20132481. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.106.635144","journal-title":"Circulation"},{"key":"1910_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/s12012-016-9365-z","author":"G Janbabai","year":"2016","unstructured":"Janbabai G, Nabati M, Faghihinia M et al (2016) Effect of enalapril on preventing anthracycline-induced cardiomyopathy. Cardiovasc Toxicol. \n                    https:\/\/doi.org\/10.1007\/s12012-016-9365-z","journal-title":"Cardiovasc Toxicol"},{"key":"1910_CR24","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.echo.2010.03.019","volume":"23","author":"L Lopez","year":"2010","unstructured":"Lopez L, Colan SD, Frommelt PC et al (2010) Recommendations for quantification methods during the performance of a pediatric echocardiogram: a report from the Pediatric Measurements Writing Group of the American Society of Echocardiography Pediatric and Congenital Heart Disease Council. J Am Soc Echocardiogr 23:465\u2013495. \n                    https:\/\/doi.org\/10.1016\/j.echo.2010.03.019","journal-title":"J Am Soc Echocardiogr"},{"key":"1910_CR25","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1016\/j.echo.2006.09.001","volume":"19","author":"WW Lai","year":"2006","unstructured":"Lai WW, Geva T, Shirali GS et al (2006) Guidelines and standards for performance of a pediatric echocardiogram: a report from the Task Force of the Pediatric Council of the American Society of Echocardiography. J Am Soc Echocardiogr 19:1413\u20131430. \n                    https:\/\/doi.org\/10.1016\/j.echo.2006.09.001","journal-title":"J Am Soc Echocardiogr"},{"key":"1910_CR26","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1161\/CIRCIMAGING.112.973321","volume":"5","author":"H Sawaya","year":"2012","unstructured":"Sawaya H, Sebag IA, Plana JC et al (2012) Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab. Circ Cardiovasc Imaging 5:596\u2013603. \n                    https:\/\/doi.org\/10.1161\/CIRCIMAGING.112.973321","journal-title":"Circ Cardiovasc Imaging"},{"key":"1910_CR27","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1016\/j.amjcard.2011.01.006","volume":"107","author":"H Sawaya","year":"2011","unstructured":"Sawaya H, Sebag IA, Plana JC et al (2011) Early detection and prediction of cardiotoxicity in chemotherapy-treated patients. Am J Cardiol 107:1375\u20131380. \n                    https:\/\/doi.org\/10.1016\/j.amjcard.2011.01.006","journal-title":"Am J Cardiol"},{"key":"1910_CR28","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1139\/cjpp-2012-0398","volume":"91","author":"C Morno\u015f","year":"2013","unstructured":"Morno\u015f C, Petrescu L (2013) Early detection of anthracycline-mediated cardiotoxicity: the value of considering both global longitudinal left ventricular strain and twist. Can J Physiol Pharmacol 91:601\u2013607. \n                    https:\/\/doi.org\/10.1139\/cjpp-2012-0398","journal-title":"Can J Physiol Pharmacol"},{"key":"1910_CR29","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/j.echo.2013.02.008","volume":"26","author":"K Negishi","year":"2013","unstructured":"Negishi K, Negishi T, Hare JL et al (2013) Independent and incremental value of deformation indices for prediction of trastuzumab-induced cardiotoxicity. J Am Soc Echocardiogr 26:493\u2013498. \n                    https:\/\/doi.org\/10.1016\/j.echo.2013.02.008","journal-title":"J Am Soc Echocardiogr"},{"key":"1910_CR30","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1093\/ehjci\/jet159","volume":"15","author":"K Negishi","year":"2014","unstructured":"Negishi K, Negishi T, Haluska BA et al (2014) Use of speckle strain to assess left ventricular responses to cardiotoxic chemotherapy and cardioprotection. Eur Heart J Cardiovasc Imaging 15:324\u2013331. \n                    https:\/\/doi.org\/10.1093\/ehjci\/jet159","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"1910_CR31","doi-asserted-by":"publisher","first-page":"133","DOI":"10.7775\/AJC.81.2.2300","volume":"81","author":"S Baratta","year":"2013","unstructured":"Baratta S, Damiano MA, Marchese ML et al (2013) Serum markers, conventional doppler echocardiography and two-dimensional systolic strain in the diagnosis of chemotherapy-induced myocardial toxicity. Argent J Cardiol 81:133\u2013138. \n                    https:\/\/doi.org\/10.7775\/AJC.81.2.2300","journal-title":"Argent J Cardiol"},{"key":"1910_CR32","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.echo.2014.07.012","volume":"27","author":"JC Plana","year":"2014","unstructured":"Plana JC, Galderisi M, Barac A et al (2014) Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 27:911\u2013939. \n                    https:\/\/doi.org\/10.1016\/j.echo.2014.07.012","journal-title":"J Am Soc Echocardiogr"},{"key":"1910_CR33","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.echo.2012.04.007","volume":"25","author":"JT Poterucha","year":"2012","unstructured":"Poterucha JT, Kutty S, Lindquist RK et al (2012) Changes in left ventricular longitudinal strain with anthracycline chemotherapy in adolescents precede subsequent decreased left ventricular ejection fraction. J Am Soc Echocardiogr 25:733\u2013740. \n                    https:\/\/doi.org\/10.1016\/j.echo.2012.04.007","journal-title":"J Am Soc Echocardiogr"},{"key":"1910_CR34","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1017\/S1047951113001182","volume":"24","author":"TJ Moon","year":"2014","unstructured":"Moon TJ, Miyamoto SD, Younoszai AK, Landeck BF (2014) Left ventricular strain and strain rates are decreased in children with normal fractional shortening after exposure to anthracycline chemotherapy. Cardiol Young 24:854\u2013865. \n                    https:\/\/doi.org\/10.1017\/S1047951113001182","journal-title":"Cardiol Young"},{"key":"1910_CR35","doi-asserted-by":"publisher","first-page":"4517","DOI":"10.1200\/JCO.2002.12.102","volume":"20","author":"SE Lipshultz","year":"2002","unstructured":"Lipshultz SE, Lipsitz SR, Sallan SE et al (2002) Long-term enalapril therapy for left ventricular dysfunction in doxorubicin-treated survivors of childhood cancer. J Clin Oncol 20:4517\u20134522. \n                    https:\/\/doi.org\/10.1200\/JCO.2002.12.102","journal-title":"J Clin Oncol"},{"key":"1910_CR36","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1200\/JCO.2004.06.022","volume":"22","author":"JH Silber","year":"2004","unstructured":"Silber JH, Cnaan A, Clark BJ et al (2004) Enalapril to prevent cardiac function decline in long-term survivors of pediatric cancer exposed to anthracyclines. J Clin Oncol 22:820\u2013828. \n                    https:\/\/doi.org\/10.1200\/JCO.2004.06.022","journal-title":"J Clin Oncol"}],"container-title":["Pediatric Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00246-018-1910-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-018-1910-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-018-1910-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T07:16:45Z","timestamp":1560842205000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00246-018-1910-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,22]]},"references-count":36,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["1910"],"URL":"https:\/\/doi.org\/10.1007\/s00246-018-1910-z","relation":{},"ISSN":["0172-0643","1432-1971"],"issn-type":[{"value":"0172-0643","type":"print"},{"value":"1432-1971","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,22]]},"assertion":[{"value":"12 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"All authors declare that there are no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}